The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study Group
- PMID: 9401073
- DOI: 10.1046/j.1365-2141.1997.4473257.x
The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study Group
Abstract
Trisomy 8 is the most frequent numerical chromosome aberration in acute myeloid leukaemia (AML). It occurs either as the sole anomaly or together with other clonal chromosome aberrations. We investigated whether accompanying chromosome anomalies influence the clinical outcome in patients with trisomy 8 and de novo AML. Since 1986, in 713 AML cases treated according to the protocols of the German AMLCG trials, chromosome analyses have been successfully performed. The overall incidence of trisomy 8 was 7.6%. Complete clinical follow-up data were available for 51 patients who were divided into three different categories: group 1: trisomy 8 as the sole cytogenetic anomaly (n = 20); group 2: trisomy 8 in addition to favourable chromosome aberrations (t(8;21)(q22;q22), t(15;17)(q22;q21), inv(16)(p13q22)) (n = 10); and group 3: trisomy 8 accompanied by other anomalies, in most cases of complex type (n = 21). Complete remission (CR) rates were 70%, 90% and 67% for groups 1, 2 and 3, respectively. Event-free survival (EFS) at 3 years differed significantly between patients with trisomy 8 only (37.5%), patients with trisomy 8 in combination with favourable aberrations (55.0%) and patients with trisomy 8 and other accompanying anomalies, mostly complex chromosome aberrations (9.0%) (group 1 v group 2: P=0.12; group 1 v group 3: P=0.005; group 2 v group 3: P=0.05). In this study patients with +8 as the sole cytogenetic anomaly had an intermediate prognosis, patients with +8 in addition to favourable chromosome aberrations maintained a good clinical outcome, and patients with +8 in combination with other abnormalities showed the worst prognosis.
Similar articles
-
Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients.Br J Haematol. 2001 Jan;112(1):118-26. doi: 10.1046/j.1365-2141.2001.02511.x. Br J Haematol. 2001. PMID: 11167792 Clinical Trial.
-
Cytogenetic abnormalities in childhood acute myeloid leukaemia: a Nordic series comprising all children enrolled in the NOPHO-93-AML trial between 1993 and 2001.Br J Haematol. 2003 May;121(4):566-77. doi: 10.1046/j.1365-2141.2003.04349.x. Br J Haematol. 2003. PMID: 12752097 Clinical Trial.
-
Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.Leukemia. 2003 Apr;17(4):731-7. doi: 10.1038/sj.leu.2402871. Leukemia. 2003. PMID: 12682630
-
Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?Best Pract Res Clin Haematol. 2007 Mar;20(1):29-37. doi: 10.1016/j.beha.2006.10.006. Best Pract Res Clin Haematol. 2007. PMID: 17336252 Review.
-
Prognostic significance of trisomy 4 as the sole cytogenetic abnormality in acute myeloid leukemia.Leuk Res. 2003 Nov;27(11):983-91. doi: 10.1016/s0145-2126(03)00076-6. Leuk Res. 2003. PMID: 12859991 Review.
Cited by
-
Cytogenetic Characteristics of de novo Acute Myeloid Leukemia in Southern Vietnam.Asian Pac J Cancer Prev. 2023 May 1;24(5):1789-1795. doi: 10.31557/APJCP.2023.24.5.1789. Asian Pac J Cancer Prev. 2023. PMID: 37247302 Free PMC article.
-
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype.Bone Marrow Transplant. 2024 Feb;59(2):264-269. doi: 10.1038/s41409-023-02167-1. Epub 2023 Dec 13. Bone Marrow Transplant. 2024. PMID: 38092959
-
Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.Cancers (Basel). 2021 Nov 13;13(22):5679. doi: 10.3390/cancers13225679. Cancers (Basel). 2021. PMID: 34830834 Free PMC article.
-
Additional chromosome aberrations in acute promyelocytic leukemia: characteristics and prognostic influence.Med Oncol. 2000 Nov;17(4):307-13. doi: 10.1007/BF02782196. Med Oncol. 2000. PMID: 11114710
-
Establishment and characterization of a novel childhood acute lymphoblastic leukemia cell line, HXEX-ALL1, with chromosome 9p and 17p deletions.Cancer Cell Int. 2019 Apr 29;19:113. doi: 10.1186/s12935-019-0834-x. eCollection 2019. Cancer Cell Int. 2019. PMID: 31168295 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources